SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023)

被引：0

作者：

Alonso-Gordoa, Teresa ^{[1
]}

Jimenez-Fonseca, Paula ^{[2
]}

Martinez-Trufero, Javier ^{[3
]}

Navarro, Miguel ^{[4
]}

Porras, Ignacio ^{[5
]}

Rubio-Casadevall, Jordi ^{[6
]}

Arregui Valles, Marta ^{[7
]}

Baste, Neus ^{[8
]}

Hernando, Jorge ^{[9
]}

Iglesias Docampo, Lara ^{[10
]}

机构：

[1] Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain

[2] Hosp Univ Cent Asturias, Med Oncol Dept, ISPA, Oviedo, Spain

[3] Hosp Univ Miguel Servet, Med Oncol Dept, Zaragoza, Spain

[4] Complejo Asistencial Univ Salamanca, Med Oncol Dept, IBSAL, Salamanca, Spain

[5] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Med Oncol Dept, Cordoba, Spain

[6] Hosp Josep Trueta, Catalan Inst Oncol Girona, Girona Biomed Res Inst IDIBGI, Med Oncol Dept,ONCOGIRPRO Grp, Girona, Spain

[7] Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, Spain

[8] Hosp Clin Barcelona, Med Oncol Dept, IDIBAPS, Barcelona, Spain

[9] Hosp Univ Vall DHebron, Med Oncol Dept, Gastrointestinal & Endocrine Tumor Unit, VHIO, Barcelona, Spain

[10] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年 / 26卷 / 11期

关键词：

Thyroid carcinoma; Molecular alterations; Multidisciplinary; Systemic treatment; PHASE-II TRIAL; ASSOCIATION GUIDELINES; DOUBLE-BLIND; LOCOREGIONAL RECURRENCE; RISK STRATIFICATION; NECK DISSECTION; OPEN-LABEL; CARCINOMA; MANAGEMENT; PAPILLARY;

D O I：

10.1007/s12094-024-03736-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Thyroid cancer (TC) represents 3% of global cancer incidence. Recent changes have optimized treatment decisions based on risk assessment, molecular profiling, and imaging assessment, leading the development of targeted agents that have modified the natural history of this disease. This increasing complexity on treatment options requires careful assessment at the different stages of the disease to provide the most suitable approach from diagnosis to long-term follow-up. This guideline aims to offer a comprehensive and practical overview on the current status and last updates of TC management.

引用

页码：2902 / 2916

页数：15

共 50 条

[1] SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
Rueda Dominguez, Antonio
Cirauqui, Beatriz
Garcia Castano, Almudena
Alvarez Cabellos, Ruth
Carral Maseda, Alberto
Castelo Fernandez, Beatriz
Iglesias Rey, Leticia
Rubio-Casadevall, Jordi
Arrazubi, Virginia
Mesia, Ricard
CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (04): : 670 - 680
[2] SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
Antonio Rueda Domínguez
Beatriz Cirauqui
Almudena García Castaño
Ruth Alvarez Cabellos
Alberto Carral Maseda
Beatriz Castelo Fernández
Leticia Iglesias Rey
Jordi Rubió-Casadevall
Virginia Arrazubi
Ricard Mesía
Clinical and Translational Oncology, 2022, 24 : 670 - 680
[3] SEOM clinical guideline thyroid cancer (2019)
E. Gallardo
J. Medina
J. C. Sánchez
A. Viúdez
E. Grande
I. Porras
T. Ramón y Cajal
J. Trigo
L. Iglesias
J. Capdevila
Clinical and Translational Oncology, 2020, 22 : 223 - 235
[4] SEOM clinical guideline thyroid cancer (2019)
Gallardo, E.
Medina, J.
Sanchez, J. C.
Viudez, A.
Grande, E.
Porras, I.
Ramon y Cajal, T.
Trigo, J.
Iglesias, L.
Capdevila, J.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (02): : 223 - 235
[5] SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023)
Perez-Fidalgo, Jose Alejandro
Galvez-Montosa, Fernando
Guerra, Eva Maria
Madariaga, Ainhoa
Manzano, Aranzazu
Martin-Lorente, Cristina
Rubio-Perez, Maria Jesus
Alarcon, Jesus
Barretina-Ginesta, Maria Pilar
Gaba, Lydia
CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (11): : 2758 - 2770
[6] SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of gastric cancer (2023)
Rivera, Fernando
Longo, Federico
Richard, Marta Martin
Richart, Paula
Alsina, Maria
Carmona, Alberto
Custodio, Ana Belen
Montes, Ana Fernandez
Gallego, Javier
Fleitas Kanonnikoff, Tania
CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (11): : 2826 - 2840
[7] SEOM clinical guideline in ovarian cancer (2020)
A. Redondo
E. Guerra
L. Manso
C. Martin-Lorente
J. Martinez-Garcia
J. A. Perez-Fidalgo
M. Q. Varela
M. J. Rubio
M. P. Barretina-Ginesta
A. Gonzalez-Martin
Clinical and Translational Oncology, 2021, 23 : 961 - 968
[8] Clinical guideline seom: hereditary colorectal cancer
Guillen-Ponce, C.
Serrano, R.
Sanchez-Heras, A. B.
Teule, A.
Chirivella, I.
Martin, T.
Martinez, E.
Morales, R.
Robles, L.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (12): : 962 - 971
[9] SEOM clinical guideline in nasopharynx cancer (2017)
M. Pastor
A. Lopez Pousa
E. del Barco
P. Perez Segura
B. Gonzalez Astorga
B. Castelo
T. Bonfill
J. Martinez Trufero
J. Jose Grau
R. Mesia
Clinical and Translational Oncology, 2018, 20 : 84 - 88
[10] SEOM Clinical Guideline in ovarian cancer (2016)
A. Santaballa
P. Barretina
A. Casado
Y. García
A. González-Martín
E. Guerra
N. Laínez
J. Martinez
A. Redondo
I. Romero
Clinical and Translational Oncology, 2016, 18 : 1206 - 1212

← 1 2 3 4 5 →